title: Dopamine dysregulation syndrome including mania related to coadministration of droxidopa.
authors.forename: Shinnosuke
authors.initials: S
authors.lastname: Saito
authors.forename: Katsutoshi
authors.initials: K
authors.lastname: Shioda
authors.forename: Kouichi
authors.initials: K
authors.lastname: Nishijima
mesh_terms: D000374:Aggression; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016739:Behavior, Addictive / Q000209:etiology; D052160:Benzothiazoles / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000209:etiology; D002230:Carbidopa / Q000627:therapeutic use; D015103:Droxidopa / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000503:physiopathology*; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology; D000077487:Pramipexole; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents; D052160:Benzothiazoles; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D000077487:Pramipexole; D015103:Droxidopa; D002230:Carbidopa